◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › M › MADAME

Madame Bioscience Public Company Limited (MADAME) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Consumer Defensive · Packaged Foods · DATA UPDATED 2026-11-03

Madame Bioscience Public Company Limited (MADAME) operates in the Packaged Foods industry and is headquartered in Bangkok, Thailand. Its market capitalization is roughly THB 864 million. In the fiscal year ended 2025-12-31, MADAME reported THB 1.5B in revenue and THB 46M in net income.

Madame Bioscience Public Company Limited, together with its subsidiaries, engages in the food business in Thailand. It operates through Packaging Business, Retail Sales of Cosmetics, Food Business, and Other Business segments.

Interactive charts & full statements → Open the MADAME valuation workbench →

MADAME Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	THB 1.6B	THB 1.5B	THB 2.1B	THB 2.3B	THB 2.2B	—
Gross Profit	THB 450M	THB 322M	THB 360M	THB 296M	THB 81M	—
Operating Income (EBIT)	THB 17M	THB 233M	THB 45M	(THB 160M)	(THB 402M)	—
Net Income	(THB 141M)	THB 46M	(THB 332M)	(THB 406M)	(THB 422M)	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MADAME Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	THB 432M	THB 378M	THB 388M	THB 385M	THB 377M	—
Gross Profit	THB 142M	THB 114M	THB 100M	THB 95M	THB 108M	—
Operating Income (EBIT)	THB 30M	THB 24M	(THB 25M)	(THB 12M)	THB 27M	—
Net Income	THB 36M	THB 22M	(THB 180M)	(THB 18M)	THB 17M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MADAME Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	THB 0M	THB 0M	THB 0M	THB 0M	THB 0M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MADAME Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Dividends Paid	THB 0M	THB 0M	THB 0M	THB 0M	THB 0M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MADAME Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	THB 1.3B	THB 1.6B	THB 2.0B	THB 2.5B	—
Total Liabilities	THB 523M	THB 1.1B	THB 1.3B	THB 1.3B	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MADAME viewer.

Other Companies in Packaged Foods

KOHINOOR · Kohinoor Foods Limited — ₹940 million
SORKON · S. Khonkaen Foods Public Company Limited — THB 938 million
0829 · Shenguan Holdings (Group) Limited — HK$937 million
KRUR · Kerur Holdings Ltd. — ₪899 million
PALASHSECU · Palash Securities Limited — ₹818 million
ZNKL · Zanlakol Ltd — ₪788 million
APN · Applied Nutrition Plc — £756 million
SAVE · Savencia SA — €738 million

← MACV All “M” companies MADE →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.